U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Durcabtagene Autoleucel
INN  
Official Name English
autologous T lymphocytes obtained from peripheral blood mononuclear cells by leukapheresis, transduced with a self-inactivating, non-replicating lentiviral vector encoding a chimeric antigen receptor (CAR) targeting human B cell maturation antigen (BCMA)
Preferred Name English
durcabtagene autoleucel [INN]
Common Name English
Code System Code Type Description
FDA UNII
D6ZL787LZ9
Created by admin on Wed Apr 02 17:18:55 GMT 2025 , Edited by admin on Wed Apr 02 17:18:55 GMT 2025
PRIMARY
SMS_ID
300000051517
Created by admin on Wed Apr 02 17:18:55 GMT 2025 , Edited by admin on Wed Apr 02 17:18:55 GMT 2025
PRIMARY
NCI_THESAURUS
C199006
Created by admin on Wed Apr 02 17:18:55 GMT 2025 , Edited by admin on Wed Apr 02 17:18:55 GMT 2025
PRIMARY
INN
12461
Created by admin on Wed Apr 02 17:18:55 GMT 2025 , Edited by admin on Wed Apr 02 17:18:55 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966